<HTML>
<HEAD>
<TITLE>page 34</TITLE>
<STYLE TYPE="text/css">
<!--
.pg{position:absolute;top:0px;left:0px;height:1056px;width:816px;}
BODY{font-size:13px;color:rgb(0,0,0);background-color:rgb(255,255,255);}
.ps0{position:absolute;top:116px;left:118px;height:11px;width:507px;}
.ps1{position:absolute;top:134px;left:118px;height:11px;width:500px;}
.ps2{position:absolute;top:152px;left:118px;height:11px;width:519px;}
.ps3{position:absolute;top:171px;left:118px;height:11px;width:504px;}
.ps4{position:absolute;top:189px;left:118px;height:11px;width:509px;}
.ps5{position:absolute;top:207px;left:118px;height:11px;width:412px;}
.ps6{position:absolute;top:234px;left:118px;height:11px;width:569px;}
.ps7{position:absolute;top:252px;left:118px;height:11px;width:556px;}
.ps8{position:absolute;top:270px;left:118px;height:11px;width:571px;}
.ps9{position:absolute;top:289px;left:118px;height:11px;width:549px;}
.ps10{position:absolute;top:307px;left:118px;height:11px;width:554px;}
.ps11{position:absolute;top:325px;left:118px;height:11px;width:550px;}
.ps12{position:absolute;top:344px;left:118px;height:11px;width:516px;}
.ps13{position:absolute;top:362px;left:118px;height:11px;width:567px;}
.ps14{position:absolute;top:380px;left:118px;height:11px;width:550px;}
.ps15{position:absolute;top:399px;left:118px;height:11px;width:506px;}
.ps16{position:absolute;top:417px;left:118px;height:11px;width:559px;}
.ps17{position:absolute;top:435px;left:118px;height:11px;width:566px;}
.ps18{position:absolute;top:454px;left:118px;height:11px;width:567px;}
.ps19{position:absolute;top:472px;left:118px;height:11px;width:529px;}
.ps20{position:absolute;top:490px;left:118px;height:11px;width:529px;}
.ps21{position:absolute;top:509px;left:118px;height:11px;width:514px;}
.ps22{position:absolute;top:527px;left:118px;height:11px;width:551px;}
.ps23{position:absolute;top:545px;left:118px;height:11px;width:565px;}
.ps24{position:absolute;top:564px;left:118px;height:11px;width:550px;}
.ps25{position:absolute;top:582px;left:118px;height:11px;width:528px;}
.ps26{position:absolute;top:600px;left:118px;height:11px;width:554px;}
.ps27{position:absolute;top:619px;left:118px;height:11px;width:491px;}
.ps28{position:absolute;top:637px;left:118px;height:11px;width:525px;}
.ps29{position:absolute;top:655px;left:118px;height:11px;width:270px;}
.ps30{position:absolute;top:682px;left:118px;height:11px;width:557px;}
.ps31{position:absolute;top:700px;left:118px;height:11px;width:530px;}
.ps32{position:absolute;top:718px;left:118px;height:11px;width:546px;}
.ps33{position:absolute;top:737px;left:118px;height:11px;width:531px;}
.ps34{position:absolute;top:755px;left:118px;height:11px;width:510px;}
.ps35{position:absolute;top:773px;left:118px;height:11px;width:512px;}
.ps36{position:absolute;top:792px;left:118px;height:11px;width:563px;}
.ps37{position:absolute;top:810px;left:118px;height:11px;width:534px;}
.ps38{position:absolute;top:828px;left:118px;height:11px;width:530px;}
.ps39{position:absolute;top:847px;left:118px;height:11px;width:565px;}
.ps40{position:absolute;top:865px;left:118px;height:11px;width:546px;}
.ps41{position:absolute;top:883px;left:118px;height:11px;width:563px;}
.ps42{position:absolute;top:902px;left:118px;height:11px;width:454px;}
.ps43{position:absolute;top:920px;left:118px;height:11px;width:522px;}
.ps44{position:absolute;top:938px;left:118px;height:11px;width:478px;}
.ps45{position:absolute;top:116px;left:462px;height:11px;width:548px;}
.ps46{position:absolute;top:134px;left:462px;height:11px;width:566px;}
.ps47{position:absolute;top:152px;left:462px;height:11px;width:551px;}
.ps48{position:absolute;top:171px;left:462px;height:11px;width:536px;}
.ps49{position:absolute;top:189px;left:462px;height:11px;width:564px;}
.ps50{position:absolute;top:207px;left:462px;height:11px;width:106px;}
.ps51{position:absolute;top:234px;left:462px;height:11px;width:532px;}
.ps52{position:absolute;top:252px;left:462px;height:11px;width:565px;}
.ps53{position:absolute;top:270px;left:462px;height:11px;width:565px;}
.ps54{position:absolute;top:289px;left:462px;height:11px;width:523px;}
.ps55{position:absolute;top:307px;left:462px;height:11px;width:538px;}
.ps56{position:absolute;top:325px;left:462px;height:11px;width:546px;}
.ps57{position:absolute;top:344px;left:462px;height:11px;width:545px;}
.ps58{position:absolute;top:362px;left:462px;height:11px;width:564px;}
.ps59{position:absolute;top:380px;left:462px;height:11px;width:488px;}
.ps60{position:absolute;top:399px;left:462px;height:11px;width:568px;}
.ps61{position:absolute;top:417px;left:462px;height:11px;width:552px;}
.ps62{position:absolute;top:435px;left:462px;height:11px;width:571px;}
.ps63{position:absolute;top:454px;left:462px;height:11px;width:502px;}
.ps64{position:absolute;top:472px;left:462px;height:11px;width:511px;}
.ps65{position:absolute;top:490px;left:462px;height:11px;width:558px;}
.ps66{position:absolute;top:509px;left:462px;height:11px;width:507px;}
.ps67{position:absolute;top:535px;left:462px;height:11px;width:554px;}
.ps68{position:absolute;top:553px;left:462px;height:11px;width:528px;}
.ps69{position:absolute;top:572px;left:462px;height:11px;width:566px;}
.ps70{position:absolute;top:590px;left:462px;height:11px;width:566px;}
.ps71{position:absolute;top:608px;left:462px;height:11px;width:564px;}
.ps72{position:absolute;top:627px;left:462px;height:11px;width:544px;}
.ps73{position:absolute;top:645px;left:462px;height:11px;width:536px;}
.ps74{position:absolute;top:663px;left:462px;height:11px;width:335px;}
.ps75{position:absolute;top:690px;left:462px;height:11px;width:505px;}
.ps76{position:absolute;top:708px;left:462px;height:11px;width:509px;}
.ps77{position:absolute;top:726px;left:462px;height:11px;width:539px;}
.ps78{position:absolute;top:745px;left:462px;height:11px;width:542px;}
.ps79{position:absolute;top:763px;left:462px;height:11px;width:567px;}
.ps80{position:absolute;top:781px;left:462px;height:11px;width:540px;}
.ps81{position:absolute;top:800px;left:462px;height:11px;width:561px;}
.ps82{position:absolute;top:818px;left:462px;height:11px;width:559px;}
.ps83{position:absolute;top:836px;left:462px;height:11px;width:558px;}
.ps84{position:absolute;top:855px;left:462px;height:11px;width:232px;}
.ps85{position:absolute;top:884px;left:462px;height:10px;width:259px;}
.ps86{position:absolute;top:901px;left:462px;height:11px;width:496px;}
.ps87{position:absolute;top:919px;left:462px;height:11px;width:557px;}
.ps88{position:absolute;top:938px;left:462px;height:11px;width:522px;}
.ps89{position:absolute;top:1013px;left:116px;height:7px;width:21px;}
.ft0{font-weight:bold;font-family:"Times New Roman",Times,serif;white-space:pre;}
.ft1{font-family:sans-serif;white-space:pre;}
.ft2{font-size:14px;font-family:sans-serif;white-space:pre;}
.ft3{font-weight:bold;font-size:11px;font-family:sans-serif;white-space:pre;}
.ft4{font-size:8px;font-family:sans-serif;white-space:pre;}
.em0{font-weight:normal;font-family:sans-serif;}
.em1{font-weight:bold;font-family:"Times New Roman",Times,serif;}
.em2{}
-->
</STYLE>
<script language="JavaScript">
<!--
function MM_reloadPage(init) {  //reloads the window if Nav4 resized
  if (init==true) with (navigator) {if ((appName=="Netscape")&&(parseInt(appVersion)==4)) {
    document.MM_pgW=innerWidth; document.MM_pgH=innerHeight; onresize=MM_reloadPage; }}
  else if (innerWidth!=document.MM_pgW || innerHeight!=document.MM_pgH) location.reload();
}
MM_reloadPage(true);
// -->
</script>
</HEAD>

<BODY>
<SPAN CLASS="pg" style="width: 700px; height: 993px">
<div id="Layer1" style="position:absolute; width:114px; height:11px; z-index:1; left: 578px; top: 945px"><a href="page35BetaBlockerThiazideHypertension.html">To 
  next page</a></div>
</SPAN> <SPAN CLASS="ps0" style="left: 25px; width: 300px; top: 50px"><SPAN CLASS="ft0">Physiological 
and Biochemical Measure-</SPAN></SPAN> <SPAN CLASS="ps1" style="left: 25px; top: 69; width: 300"><SPAN CLASS="ft0">ments.&#160;&#160;<SPAN CLASS="em0">Some</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">clinicians</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">have</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">found</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">certain</SPAN></SPAN></SPAN> 
<SPAN CLASS="ps2" style="width: 300; left: 25px; top: 88"><SPAN CLASS="ft1">physiological 
and biochemical measurements</SPAN></SPAN> <SPAN CLASS="ps3" style="width: 300; left: 25px; top: 107"><SPAN CLASS="ft1">(e.g., 
body weight, heart rate, plasma renin</SPAN></SPAN> <SPAN CLASS="ps4" style="width: 300; left: 25px; top: 126px"><SPAN CLASS="ft1">activity, 
hemodynamic measurements) to be</SPAN></SPAN> <SPAN CLASS="ps5" style="width: 300; left: 25px; top: 145"><SPAN CLASS="ft1">helpful 
in choosing specific therapy.</SPAN></SPAN> <SPAN CLASS="ps6" style="width: 300; left: 25px; top: 172px"><SPAN CLASS="ft0">Economic 
Considerations.&#160;&#160;<SPAN CLASS="em0">The</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">cost</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">of</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">therapy</SPAN></SPAN></SPAN> 
<SPAN CLASS="ps7" style="width: 300; left: 25px; top: 191px"><SPAN CLASS="ft1">may 
be a barrier to controlling high blood pres-</SPAN></SPAN> <SPAN CLASS="ps8" style="width: 300; left: 25px; top: 210px"><SPAN CLASS="ft1">sure 
and should be an important consideration in</SPAN></SPAN> <SPAN CLASS="ps9" style="width: 300; left: 25px; top: 229px"><SPAN CLASS="ft1">selecting 
antihypertensive medication. &#160;Generic</SPAN></SPAN> <SPAN CLASS="ps10" style="width: 300; left: 25px; top: 248px"><SPAN CLASS="ft1">formulations 
are acceptable. &#160;Nongeneric newer</SPAN></SPAN> <SPAN CLASS="ps11" style="width: 300; left: 25px; top: 267px"><SPAN CLASS="ft1">drugs 
are usually more expensive than diuretics</SPAN></SPAN> <SPAN CLASS="ps12" style="width: 300; left: 25px; top: 286px"><SPAN CLASS="ft1">or 
beta-blockers. &#160;If newer agents eventually</SPAN></SPAN> <SPAN CLASS="ps13" style="width: 300; left: 25px; top: 305px"><SPAN CLASS="ft1">prove 
to be equally effective, then cost should be</SPAN></SPAN> <SPAN CLASS="ps14" style="width: 300; left: 25px; top: 324px"><SPAN CLASS="ft1">considered 
in choosing them for initial therapy;</SPAN></SPAN> <SPAN CLASS="ps15" style="width: 300; left: 25px; top: 343px"><SPAN CLASS="ft1">if 
they prove to be more effective, then cost</SPAN></SPAN> <SPAN CLASS="ps16" style="width: 300; left: 25px; top: 362px"><SPAN CLASS="ft1">should 
be a secondary consideration. &#160;Treatment</SPAN></SPAN> <SPAN CLASS="ps17" style="width: 300; left: 25px; top: 381px"><SPAN CLASS="ft1">costs 
include not only the price of drugs but also</SPAN></SPAN> <SPAN CLASS="ps18" style="width: 300; left: 25px; top: 400px"><SPAN CLASS="ft1">the 
expense of routine or special laboratory tests,</SPAN></SPAN> <SPAN CLASS="ps19" style="width: 300; left: 25px; top: 419px"><SPAN CLASS="ft1">supplemental 
therapies, office visits, and time</SPAN></SPAN> <SPAN CLASS="ps20" style="width: 300; left: 25px; top: 438px"><SPAN CLASS="ft1">lost 
from work for visits to physicians&#146; offices.</SPAN></SPAN> <SPAN CLASS="ps21" style="width: 300; left: 25px; top: 457px"><SPAN CLASS="ft1">The 
costs of medications may be reduced by</SPAN></SPAN> <SPAN CLASS="ps22" style="width: 300; left: 25px; top: 476px"><SPAN CLASS="ft1">using 
combination tablets and generic formula-</SPAN></SPAN> <SPAN CLASS="ps23" style="width: 300; left: 25px; top: 495px"><SPAN CLASS="ft1">tions. 
&#160;Patients should be advised to check prices</SPAN></SPAN> <SPAN CLASS="ps24" style="width: 300; left: 25px; top: 514px"><SPAN CLASS="ft1">at 
different sources. &#160;Some larger tablets can be</SPAN></SPAN> <SPAN CLASS="ps25" style="width: 300; left: 25px; top: 533px"><SPAN CLASS="ft1">divided, 
saving money when larger doses cost</SPAN></SPAN> <SPAN CLASS="ps26" style="width: 300; left: 25px; top: 552px"><SPAN CLASS="ft1">little 
more than smaller doses. &#160;Some sustained-</SPAN></SPAN> <SPAN CLASS="ps27" style="width: 300; left: 25px; top: 571px"><SPAN CLASS="ft1">release 
formulations should not be divided</SPAN></SPAN> <SPAN CLASS="ps28" style="width: 300; left: 25px; top: 590px"><SPAN CLASS="ft1">because 
cutting the tablet eliminates the sus-</SPAN></SPAN> <SPAN CLASS="ps29" style="width: 300; left: 25px; top: 609px"><SPAN CLASS="ft1">tained-release 
function.</SPAN></SPAN> <SPAN CLASS="ps30" style="width: 300px; left: 25px; top: 636px"><SPAN CLASS="ft0">Managed 
Care.&#160;&#160;<SPAN CLASS="em0">Because</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">high</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">blood</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">pressure</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">is</SPAN></SPAN></SPAN> <SPAN CLASS="ps31" style="width: 300; left: 25px; top: 655px"><SPAN CLASS="ft1">so 
common, its management requires a major</SPAN></SPAN> <SPAN CLASS="ps32" style="width: 300; left: 25px; top: 674px"><SPAN CLASS="ft1">commitment 
from clinicians and managed care</SPAN></SPAN> <SPAN CLASS="ps33" style="width: 300; left: 25px; top: 693px"><SPAN CLASS="ft1">organizations. 
&#160;This commitment will need to</SPAN></SPAN> <SPAN CLASS="ps34" style="width: 300; left: 25px; top: 712px"><SPAN CLASS="ft1">expand 
even further because the majority of</SPAN></SPAN> <SPAN CLASS="ps35" style="width: 300; left: 25px; top: 731px"><SPAN CLASS="ft1">patients 
with hypertension do not have ade-</SPAN></SPAN> <SPAN CLASS="ps36" style="width: 300; left: 25px; top: 750px"><SPAN CLASS="ft1">quately 
controlled blood pressure (see chapter 1)</SPAN></SPAN> <SPAN CLASS="ps37" style="width: 300; left: 25px; top: 769px"><SPAN CLASS="ft1">and 
additional demands will develop from the</SPAN></SPAN> <SPAN CLASS="ps38" style="width: 300; left: 25px; top: 788px"><SPAN CLASS="ft1">projected 
increase in numbers of persons with</SPAN></SPAN> <SPAN CLASS="ps39" style="width: 300; left: 25px; top: 807px"><SPAN CLASS="ft1">hypertension 
due to the aging of the population.</SPAN></SPAN> <SPAN CLASS="ps40" style="width: 300; left: 25px; top: 826px"><SPAN CLASS="ft1">However, 
the cost of managing hypertension is</SPAN></SPAN> <SPAN CLASS="ps41" style="width: 300; left: 25px; top: 845px"><SPAN CLASS="ft1">lower 
overall than the sum of direct and indirect</SPAN></SPAN> <SPAN CLASS="ps42" style="width: 300; left: 25px; top: 864px"><SPAN CLASS="ft1">costs 
that may be avoided by reducing </SPAN></SPAN> <SPAN CLASS="ps43" style="width: 300; left: 25px; top: 883px"><SPAN CLASS="ft1">hypertension-associated 
heart disease, stroke,</SPAN></SPAN> <SPAN CLASS="ps44" style="width: 300; left: 25px; top: 902px"><SPAN CLASS="ft1">and 
renal failure, especially because these</SPAN></SPAN> <SPAN CLASS="ps45" style="left: 369px; top: 50px; width: 325px; height: 11px"><SPAN CLASS="ft1">adverse 
events often lead to expensive hospital-</SPAN></SPAN> <SPAN CLASS="ps46" style="width: 325px; height: 11px; left: 369px; top: 69px"><SPAN CLASS="ft1">izations, 
surgical procedures, and high-cost tech-</SPAN></SPAN> <SPAN CLASS="ps47" style="width: 325px; height: 11px; left: 369px; top: 88px"><SPAN CLASS="ft1">nologies.<SPAN CLASS="em2"><SUP>131<SPAN CLASS="em1">Pr,</SPAN>132<SPAN CLASS="em1">Pr,</SPAN>133<SPAN CLASS="em1">Pr</SPAN></SUP></SPAN>&#160;&#160;Randomized 
controlled</SPAN></SPAN> <SPAN CLASS="ps48" style="width: 325px; left: 369px; top: 107px"><span class="ft1">trials 
have demonstrated that these reductions</span></SPAN> <SPAN CLASS="ps49" style="width: 325px; left: 369px; top: 126px"><SPAN CLASS="ft1">occur 
in a relatively short time and are sustained</SPAN></SPAN> <SPAN CLASS="ps50" style="width: 325px; left: 369px; top: 145px"><SPAN CLASS="ft1">for 
years.</SPAN></SPAN> <SPAN CLASS="ps51" style="width: 325px; left: 369px; top: 172px"><SPAN CLASS="ft1">Managed 
care programs offer the opportunity</SPAN></SPAN> <SPAN CLASS="ps52" style="width: 325px; left: 369px; top: 191px"><SPAN CLASS="ft1">for 
a coordinated approach to care, using various</SPAN></SPAN> <SPAN CLASS="ps53" style="width: 325px; left: 369px; top: 210px"><SPAN CLASS="ft1">health 
care professionals and featuring an appro-</SPAN></SPAN> <SPAN CLASS="ps54" style="width: 325px; left: 369px; top: 229px"><SPAN CLASS="ft1">priate 
frequency of office visits, short waiting</SPAN></SPAN> <SPAN CLASS="ps55" style="width: 325px; left: 369px; top: 248px"><SPAN CLASS="ft1">times, 
supportive patient counseling, and con-</SPAN></SPAN> <SPAN CLASS="ps56" style="width: 325px; left: 369px; top: 267px"><SPAN CLASS="ft1">trolled 
formularies. &#160;The outcomes of the man-</SPAN></SPAN> <SPAN CLASS="ps57" style="width: 325px; left: 369px; top: 286px"><SPAN CLASS="ft1">agement 
of hypertension will need to be moni-</SPAN></SPAN> <SPAN CLASS="ps58" style="width: 325px; left: 369px; top: 305px"><SPAN CLASS="ft1">tored, 
in keeping with the requirements of orga-</SPAN></SPAN> <SPAN CLASS="ps59" style="width: 325px; left: 369px; top: 324px"><SPAN CLASS="ft1">nizations 
that monitor quality, such as the</SPAN></SPAN> <SPAN CLASS="ps60" style="width: 325px; left: 369px; top: 343px"><SPAN CLASS="ft1">Health 
Plan Employer Data and Information Set</SPAN></SPAN> <SPAN CLASS="ps61" style="width: 325px; left: 369px; top: 362px"><SPAN CLASS="ft1">(HEDIS). 
&#160;These outcomes may be divided into</SPAN></SPAN> <SPAN CLASS="ps62" style="width: 325px; left: 369px; top: 381px"><SPAN CLASS="ft1">three 
categories: &#160;immediate (e.g., blood pressure</SPAN></SPAN> <SPAN CLASS="ps63" style="width: 325px; left: 369px; top: 400px"><SPAN CLASS="ft1">levels, 
percentage of adherence to therapy),</SPAN></SPAN> <SPAN CLASS="ps64" style="width: 325px; left: 369px; top: 419px"><SPAN CLASS="ft1">intermediate 
(e.g., cardiac or renal function,</SPAN></SPAN> <SPAN CLASS="ps65" style="width: 325px; left: 369px; top: 438px"><SPAN CLASS="ft1">health 
resource utilization), and long-term (e.g.,</SPAN></SPAN> <SPAN CLASS="ps66" style="width: 325px; left: 369px; top: 457px"><SPAN CLASS="ft1">morbidity 
and mortality, cost-effectiveness).</SPAN></SPAN> <SPAN CLASS="ps67" style="width: 325px; left: 369px; top: 484px"><SPAN CLASS="ft1">Hypertension 
specialists may play an important</SPAN></SPAN> <SPAN CLASS="ps68" style="width: 325px; left: 369px; top: 503px"><SPAN CLASS="ft1">role 
in providing more cost-effective manage-</SPAN></SPAN> <SPAN CLASS="ps69" style="width: 325px; left: 369px; top: 522px"><SPAN CLASS="ft1">ment 
of high blood pressure by adapting nation-</SPAN></SPAN> <SPAN CLASS="ps70" style="width: 325px; left: 369px; top: 541px"><SPAN CLASS="ft1">al 
guidelines for local implementation, providing</SPAN></SPAN> <SPAN CLASS="ps71" style="width: 325px; left: 369px; top: 560px"><SPAN CLASS="ft1">guidance 
for new drugs and diagnostic methods,</SPAN></SPAN> <SPAN CLASS="ps72" style="width: 325px; left: 369px; top: 579px"><SPAN CLASS="ft1">and 
managing patients with identifiable causes</SPAN></SPAN> <SPAN CLASS="ps73" style="width: 325px; left: 369px; top: 598px"><SPAN CLASS="ft1">of 
hypertension, resistance to therapy, or com-</SPAN></SPAN> <SPAN CLASS="ps74" style="width: 325px; left: 369px; top: 617px"><SPAN CLASS="ft1">plex 
concomitant conditions.</SPAN></SPAN> <SPAN CLASS="ps75" style="width: 325px; left: 369px; top: 644px"><SPAN CLASS="ft0">Drug 
Interactions.&#160;&#160;<SPAN CLASS="em0">As</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">shown</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">in</SPAN><SPAN CLASS="em0"> </SPAN><SPAN CLASS="em0">table</SPAN><SPAN CLASS="em0"> 
</SPAN><SPAN CLASS="em0">11,</SPAN></SPAN></SPAN> <SPAN CLASS="ps76" style="width: 325px; left: 369px; top: 663px"><SPAN CLASS="ft1">some 
drug interactions may be helpful. &#160;For</SPAN></SPAN> <SPAN CLASS="ps77" style="width: 325px; left: 369px; top: 682px"><SPAN CLASS="ft1">example, 
diuretics that act on different sites in</SPAN></SPAN> <SPAN CLASS="ps78" style="width: 325px; left: 369px; top: 701px"><SPAN CLASS="ft1">the 
nephron, such as furosemide and thiazides,</SPAN></SPAN> <SPAN CLASS="ps79" style="width: 325px; left: 369px; top: 720px"><SPAN CLASS="ft1">increase 
natiuresis and diuresis, and certain calci-</SPAN></SPAN> <SPAN CLASS="ps80" style="width: 325px; left: 369px; top: 739px"><SPAN CLASS="ft1">um 
antagonists reduce the required amount of</SPAN></SPAN> <SPAN CLASS="ps81" style="width: 325px; left: 369px; top: 758px"><SPAN CLASS="ft1">cyclosporine. 
&#160;Other interactions are deleterious:</SPAN></SPAN> <SPAN CLASS="ps82" style="width: 325px; left: 369px; top: 777px"><SPAN CLASS="ft1">nonsteroidal 
anti-inflammatory drugs (NSAIDs)</SPAN></SPAN> <SPAN CLASS="ps83" style="width: 325px; left: 369px; top: 796px"><SPAN CLASS="ft1">may 
blunt the action of diuretics, beta-blockers,</SPAN></SPAN> <SPAN CLASS="ps84" style="width: 325px; left: 369px; top: 815px"><SPAN CLASS="ft1">and 
ACE inhibitors.</SPAN></SPAN> <SPAN CLASS="ps85" style="width: 325px; left: 369px; top: 842px"><SPAN CLASS="ft3">Dosage 
and Followup</SPAN></SPAN> <SPAN CLASS="ps86" style="width: 325px; left: 369px; top: 864px"><SPAN CLASS="ft1">Therapy 
for most patients (uncomplicated </SPAN></SPAN> <SPAN CLASS="ps87" style="width: 325px; left: 369px; top: 883"><SPAN CLASS="ft1">hypertension, 
stages 1 and 2) should begin with</SPAN></SPAN> <SPAN CLASS="ps88" style="width: 325px; left: 369px; top: 902px"><SPAN CLASS="ft1">the 
lowest dosage listed in table 7 to prevent</SPAN></SPAN> <SPAN CLASS="ps89" style="width: 21px; left: 25px; top: 960"><SPAN CLASS="ft4">34</SPAN></SPAN> 
</BODY>

</HTML>
